Sight Sciences [SGHT] vs Stryker [SYK] Detailed Stock Comparison

Sight Sciences Inc.

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Sight Sciences Inc. wins in 6 metrics, Stryker Corporation wins in 12 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sight Sciences Inc. Stryker Corporation Better
P/E Ratio (TTM) N/A 39.21 N/A
Price-to-Book Ratio 3.66 5.62 Sight Sciences Inc.
Debt-to-Equity Ratio 63.77 72.97 Sight Sciences Inc.
PEG Ratio -7.85 0.72 Stryker Corporation
EV/EBITDA -5.39 19.90 Stryker Corporation
Profit Margin (TTM) -49.67% 12.92% Stryker Corporation
Operating Margin (TTM) -18.00% 27.24% Stryker Corporation
EBITDA Margin (TTM) N/A 27.24% N/A
Return on Equity -50.74% 15.08% Stryker Corporation
Return on Assets (TTM) -16.61% 7.92% Stryker Corporation
Free Cash Flow (TTM) $-29.92M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return 31.71% -20.27% Sight Sciences Inc.
Price-to-Sales Ratio (TTM) 3.07 5.02 Sight Sciences Inc.
Enterprise Value $182.12M $138.30B Stryker Corporation
EV/Revenue Ratio 2.35 5.51 Sight Sciences Inc.
Gross Profit Margin (TTM) 87.26% 64.54% Sight Sciences Inc.
Revenue per Share (TTM) $1 $66 Stryker Corporation
Earnings per Share (Diluted) $-0.74 $8.40 Stryker Corporation
Beta (Stock Volatility) 2.49 0.93 Stryker Corporation
Short % of Float 2.70% 1.20% Stryker Corporation

Sight Sciences Inc. vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

SGHT
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sight Sciences Inc.0.00%-13.03%2.84%-22.78%-47.71%-41.98%
Stryker Corporation0.58%-6.29%0.83%-24.22%-20.01%-15.76%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sight Sciences Inc.31.71%-35.37%-85.14%-85.14%-85.14%-85.14%
Stryker Corporation-20.27%9.63%21.15%168.66%406.79%583.29%

Performance & Financial Health Analysis: Sight Sciences Inc. vs Stryker Corporation

MetricSGHTSYK
Market Information
Market Cap i$237.20M$126.25B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i460,0651,881,406
90 Day Avg. Volume i341,5852,161,139
Last Close$4.34$295.00
52 Week Range$3.11 - $9.24$281.00 - $404.87
% from 52W High-53.01%-27.14%
All-Time High$42.57 (Aug 02, 2021)$406.19 (Jan 27, 2025)
% from All-Time High-89.81%-27.37%
Growth Metrics
Quarterly Revenue Growth0.07%0.11%
Quarterly Earnings Growth0.07%0.56%
Financial Health
Profit Margin (TTM) i-0.50%0.13%
Operating Margin (TTM) i-0.18%0.27%
Return on Equity (TTM) i-0.51%0.15%
Debt to Equity (MRQ) i63.7772.97
Cash & Liquidity
Book Value per Share (MRQ)$1.20$58.61
Cash per Share (MRQ)$1.70$10.71
Operating Cash Flow (TTM) i$-29,694,000$5.04B
Levered Free Cash Flow (TTM) i$-16,124,625$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: Sight Sciences Inc. vs Stryker Corporation

MetricSGHT (Apr 26, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A39.21
Forward P/E i-7.8519.67
PEG Ratio i-7.850.72
Price to Sales (TTM) i3.075.02
Price to Book (MRQ) i3.665.62
Market Capitalization
Market Capitalization i$237.20M$126.25B
Enterprise Value i$182.12M$138.30B
Enterprise Value Metrics
Enterprise to Revenue i2.355.51
Enterprise to EBITDA i-5.3919.90
Risk & Other Metrics
Beta i2.490.93
Book Value per Share (MRQ) i$1.20$58.61

Financial Statements Comparison: Sight Sciences Inc. vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSGHT (2025)SYK (2025)
Revenue/Sales i77.36M25.12B
Cost of Goods Sold i10.70M9.05B
COGS % of Revenue i13.8%36.0%
Gross Profit i66.67M16.07B
Gross Margin i86.2%64.0%
Research & Development i14.61M1.62B
Operating Income (EBIT) i-37.10M5.06B
Operating Margin i-48.0%20.1%
EBITDA i-36.76M6.48B
EBITDA Margin i-47.5%25.8%
Pre-Tax Income i-38.42M4.51B
Pre-Tax Income % of Revenue i-49.7%18.0%
Income Tax i10,0001.27B
Income Tax % of Revenue i0.0%5.0%
Net Income (Profit) i-38.43M3.25B
Profit Margin i-49.7%12.9%

Balance Sheet & Liquidity Metrics

MetricSGHT (2025)SYK (2025)
Cash & Equivalents i91.97M4.01B
Total Current Assets i112.73M14.76B
Total Current Assets % of Revenue i145.7%58.7%
Total Current Liabilities i11.03M7.79B
Total Current Liabilities % of Revenue i14.3%31.0%
Long-Term Debt i40.30M14.86B
Long-Term Debt % of Revenue i52.1%59.2%
Total Shareholders Equity i63.94M22.42B
Retained Earnings i-384.72M20.47B
Retained Earnings % of Revenue i-497.3%81.5%
Property, Plant & Equipment i2.65M1.79B

Cash Flow Statement Comparison

MetricSGHT (2025)SYK (2025)
Operating Cash Flow i-24.47M4.70B
Operating Cash Flow % of Revenue i-31.6%18.7%
Capital Expenditures i-224,000-761.00M
Free Cash Flow i-29.92M4.28B
FCF Margin i-38.7%17.1%
Debt Repayment i0-1.40B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSGHTSYK
Shares Short i1.07M4.42M
Short Ratio i2.421.95
Short % of Float i2.70%1.20%
Shares Outstanding i53.49M382.50M
Float Shares i35.29M346.55M
% Held by Insiders i20.96%5.37%
% Held by Institutions i48.49%82.09%
% Held by Public i30.55%12.54%

Dividend Analysis & Yield Comparison: Sight Sciences Inc. vs Stryker Corporation

MetricSGHTSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025